{"transactions":[{"id":813840,"issuer":{"id":7610,"kind":"organization","name":"GUIDED THERAPEUTICS INC"},"owners":[{"id":53500,"kind":"person","name":"Grujic Alan","position":1,"cik":"0001980904","reported_name":"Grujic Alan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2026-04-07T21:10:58.000Z","date":"2026-03-10","kind":"grant","planned":false,"acquired":true,"shares":110000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth of the shares subject to the award vested on March 10,2026; the remaining shares will vest monthly, starting on June 10, 2026, subject to the reporting person's continued service on each such date, until the award is fully vested on March 9, 2029."}],"balance_after":110000,"derivative":{"exercise_price":0.29,"expiration_date":"2036-03-09","underlying":"Common Stock","underlying_shares":110000},"source":{"system":"sec-edgar","filing":"0001477932-26-002054","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/924515/000147793226002054/form4.xml","form_type":"4"}},{"id":1047125,"issuer":{"id":7610,"kind":"organization","name":"GUIDED THERAPEUTICS INC"},"owners":[{"id":53500,"kind":"person","name":"Grujic Alan","position":1,"cik":"0001980904","reported_name":"Grujic Alan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants","published_at":"2025-09-05T20:25:49.000Z","date":"2025-08-29","kind":"purchase","planned":false,"acquired":true,"shares":152108,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"On August 29, 2025, the Company closed on Tranche 4 Private Financing. The Company simultaneously entered into a Securities Purchase Agreement and an exchange agreement with Mr. Grujic, whereby Mr. Grujic agreed to exchange a $25,000 note payable and accrued interest of $2,379.45 for an aggregate of 152,108 units, each unit consisting of one share of common stock and one warrant to purchase up to 152,108 shares of common stock (the \"August Warrants\"). The August Warrants were immediately exercisable upon issuance and will expire in four years following the issuance date and have an exercise price of $0.25 per share."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On August 29, 2025, the Company closed on Tranche 4 Private Financing. The Company simultaneously entered into a Securities Purchase Agreement and an exchange agreement with Mr. Grujic, whereby Mr. Grujic agreed to exchange a $25,000 note payable and accrued interest of $2,379.45 for an aggregate of 152,108 units, each unit consisting of one share of common stock and one warrant to purchase up to 152,108 shares of common stock (the \"August Warrants\"). The August Warrants were immediately exercisable upon issuance and will expire in four years following the issuance date and have an exercise price of $0.25 per share."}],"balance_after":177108,"derivative":{"exercise_price":0.25,"exercise_date":"2025-08-29","expiration_date":"2029-08-28","underlying":"Common Stock","underlying_shares":152108},"source":{"system":"sec-edgar","filing":"0001477932-25-006531","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/924515/000147793225006531/form4.xml","form_type":"4"}},{"id":1047124,"issuer":{"id":7610,"kind":"organization","name":"GUIDED THERAPEUTICS INC"},"owners":[{"id":53500,"kind":"person","name":"Grujic Alan","position":1,"cik":"0001980904","reported_name":"Grujic Alan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-05T20:25:49.000Z","date":"2025-08-29","kind":"purchase","planned":false,"acquired":true,"shares":152108,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"On August 29, 2025, the Company closed on Tranche 4 Private Financing. The Company simultaneously entered into a Securities Purchase Agreement and an exchange agreement with Mr. Grujic, whereby Mr. Grujic agreed to exchange a $25,000 note payable and accrued interest of $2,379.45 for an aggregate of 152,108 units, each unit consisting of one share of common stock and one warrant to purchase up to 152,108 shares of common stock (the \"August Warrants\"). The August Warrants were immediately exercisable upon issuance and will expire in four years following the issuance date and have an exercise price of $0.25 per share."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On August 29, 2025, the Company closed on Tranche 4 Private Financing. The Company simultaneously entered into a Securities Purchase Agreement and an exchange agreement with Mr. Grujic, whereby Mr. Grujic agreed to exchange a $25,000 note payable and accrued interest of $2,379.45 for an aggregate of 152,108 units, each unit consisting of one share of common stock and one warrant to purchase up to 152,108 shares of common stock (the \"August Warrants\"). The August Warrants were immediately exercisable upon issuance and will expire in four years following the issuance date and have an exercise price of $0.25 per share."}],"balance_after":1817541,"source":{"system":"sec-edgar","filing":"0001477932-25-006531","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/924515/000147793225006531/form4.xml","form_type":"4"}},{"id":1047123,"issuer":{"id":7610,"kind":"organization","name":"GUIDED THERAPEUTICS INC"},"owners":[{"id":53500,"kind":"person","name":"Grujic Alan","position":1,"cik":"0001980904","reported_name":"Grujic Alan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-05T20:25:49.000Z","date":"2025-08-21","kind":"other","planned":false,"acquired":true,"shares":200000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On August 21, 2025, Mr. Grujic converted 50 shares of Series E preferred stock into 200,000 shares of common stock. The Series E preferred stock had a stated value of $1,000 and $0.25 conversion price."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 21, 2025, Mr. Grujic converted 50 shares of Series E preferred stock into 200,000 shares of common stock. The Series E preferred stock had a stated value of $1,000 and $0.25 conversion price."}],"balance_after":1665433,"source":{"system":"sec-edgar","filing":"0001477932-25-006531","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/924515/000147793225006531/form4.xml","form_type":"4"}},{"id":1047122,"issuer":{"id":7610,"kind":"organization","name":"GUIDED THERAPEUTICS INC"},"owners":[{"id":53500,"kind":"person","name":"Grujic Alan","position":1,"cik":"0001980904","reported_name":"Grujic Alan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Preferred Series E Stock","published_at":"2025-09-05T20:25:49.000Z","date":"2025-08-21","kind":"other","planned":false,"acquired":false,"shares":50,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On August 21, 2025, Mr. Grujic converted 50 shares of Series E preferred stock into 200,000 shares of common stock. The Series E preferred stock had a stated value of $1,000 and $0.25 conversion price."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 21, 2025, Mr. Grujic converted 50 shares of Series E preferred stock into 200,000 shares of common stock. The Series E preferred stock had a stated value of $1,000 and $0.25 conversion price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001477932-25-006531","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/924515/000147793225006531/form4.xml","form_type":"4"}},{"id":1047121,"issuer":{"id":7610,"kind":"organization","name":"GUIDED THERAPEUTICS INC"},"owners":[{"id":53500,"kind":"person","name":"Grujic Alan","position":1,"cik":"0001980904","reported_name":"Grujic Alan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-05T20:25:49.000Z","date":"2025-08-21","kind":"other","planned":false,"acquired":true,"shares":17408,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued for payment of accrued dividends on the reporting individual's Series E preferred stock, at a conversion price of $0.2298."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued for payment of accrued dividends on the reporting individual's Series E preferred stock, at a conversion price of $0.2298."}],"balance_after":1465433,"source":{"system":"sec-edgar","filing":"0001477932-25-006531","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/924515/000147793225006531/form4.xml","form_type":"4"}},{"id":1114134,"issuer":{"id":7610,"kind":"organization","name":"GUIDED THERAPEUTICS INC"},"owners":[{"id":53500,"kind":"person","name":"Grujic Alan","position":1,"cik":"0001980904","reported_name":"Grujic Alan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2025-06-12T23:20:43.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":110000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth of the shares subject to the award vested on June 3, 2025; the remaining shares will vest monthly, starting on September 3, 2025, subject to the reporting person's continued service on each such date, until the award is fully vested on June 2, 2028."}],"balance_after":110000,"derivative":{"exercise_price":0.14,"expiration_date":"2035-06-02","underlying":"Common Stock","underlying_shares":110000},"source":{"system":"sec-edgar","filing":"0001477932-25-004560","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/924515/000147793225004560/form4.xml","form_type":"4"}},{"id":1418201,"issuer":{"id":7610,"kind":"organization","name":"GUIDED THERAPEUTICS INC"},"owners":[{"id":53500,"kind":"person","name":"Grujic Alan","position":1,"cik":"0001980904","reported_name":"Grujic Alan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants","published_at":"2024-09-03T20:50:47.000Z","date":"2024-09-02","kind":"other","planned":false,"acquired":false,"shares":800000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Warrants to purchase an aggregate of 800,000 shares of Common Stock at $0.50 per share expired on September 2, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Warrants to purchase an aggregate of 800,000 shares of Common Stock at $0.50 per share expired on September 2, 2024."}],"balance_after":500000,"derivative":{"exercise_price":0.5,"exercise_date":"2022-09-02","expiration_date":"2024-09-02","underlying":"Common Stock","underlying_shares":800000},"source":{"system":"sec-edgar","filing":"0001477932-24-005458","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/924515/000147793224005458/form4.xml","form_type":"4"}},{"id":1418200,"issuer":{"id":7610,"kind":"organization","name":"GUIDED THERAPEUTICS INC"},"owners":[{"id":53500,"kind":"person","name":"Grujic Alan","position":1,"cik":"0001980904","reported_name":"Grujic Alan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants","published_at":"2024-09-03T20:50:47.000Z","date":"2024-07-31","kind":"other","planned":false,"acquired":true,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On July 31, 2024, the Company issued a $25,000 note payable to Mr. Grujic. In conjunction with the note, the Company also issued four-year warrants to purchase an aggregate of 25,000 shares of Common Stock at $0.25 per share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On July 31, 2024, the Company issued a $25,000 note payable to Mr. Grujic. In conjunction with the note, the Company also issued four-year warrants to purchase an aggregate of 25,000 shares of Common Stock at $0.25 per share."}],"balance_after":25000,"derivative":{"exercise_price":0.25,"exercise_date":"2024-07-31","expiration_date":"2028-07-30","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001477932-24-005458","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/924515/000147793224005458/form4.xml","form_type":"4"}},{"id":1418199,"issuer":{"id":7610,"kind":"organization","name":"GUIDED THERAPEUTICS INC"},"owners":[{"id":53500,"kind":"person","name":"Grujic Alan","position":1,"cik":"0001980904","reported_name":"Grujic Alan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2024-09-03T20:50:47.000Z","date":"2024-07-09","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth of the shares subject to the award vested on July 9, 2024; the remaining shares will vest monthly, starting on October 9, 2024, subject to the reporting person's continued service on each such date, until the award is fully vested on July 8, 2027."}],"balance_after":100000,"derivative":{"exercise_price":0.12,"expiration_date":"2034-07-08","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001477932-24-005458","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/924515/000147793224005458/form4.xml","form_type":"4"}},{"id":1424608,"issuer":{"id":7610,"kind":"organization","name":"GUIDED THERAPEUTICS INC"},"owners":[{"id":53500,"kind":"person","name":"Grujic Alan","position":1,"cik":"0001980904","reported_name":"Grujic Alan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-23T18:15:13.000Z","date":"2024-08-21","kind":"other","planned":false,"acquired":true,"shares":36602,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued for payment of accrued dividends on the reporting individual's Series E preferred stock, at a conversion price of $0.1093."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued for payment of accrued dividends on the reporting individual's Series E preferred stock, at a conversion price of $0.1093."}],"balance_after":1448025,"source":{"system":"sec-edgar","filing":"0001477932-24-005227","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/924515/000147793224005227/form4.xml","form_type":"4"}},{"id":1784158,"issuer":{"id":7610,"kind":"organization","name":"GUIDED THERAPEUTICS INC"},"owners":[{"id":53500,"kind":"person","name":"Grujic Alan","position":1,"cik":"0001980904","reported_name":"Grujic Alan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-11T16:44:56.000Z","date":"2023-08-21","kind":"other","planned":false,"acquired":true,"shares":22514,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were issued for payment of accrued dividends on the reporting individual's Series E preferred stock, at a conversion price of $0.1777."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued for payment of accrued dividends on the reporting individual's Series E preferred stock, at a conversion price of $0.1777."}],"balance_after":1411423,"source":{"system":"sec-edgar","filing":"0001477932-23-006793","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/924515/000147793223006793/form4.xml","form_type":"4"}}]}